Literature DB >> 30739315

Contemporary Drug-Drug Interactions in HIV Treatment.

Aaron S Devanathan1, Daijha J C Anderson1, Mackenzie L Cottrell1, Erin M Burgunder1, Ashley C Saunders1, Angela D M Kashuba1,2.   

Abstract

Despite development of modern antiretrovirals with lower drug interaction potential than their predecessors, drug interaction challenges remain. Standard treatment regimens still require multiple antiretrovirals that may cause, or may be the target of, drug interactions. Additionally, people living with HIV are living longer and often present with comorbid conditions that require concomitant long-term drug therapy. Also, treatment of infectious diseases in resource-limited settings can result in significant interactions. In this review, we describe absorption, distribution, metabolism, and excretion pathways as they relate to relevant drug interactions with antiretrovirals along with the potential clinical consequences of these interactions. We highlight clinical data that illustrate pertinent interactions and provide tools to assist in predicting drug interactions in the absence of clinical data. Given these tools and thoughtful consideration of drug combinations, drug therapy in people living with HIV can be safely and effectively managed throughout their lifetime.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30739315     DOI: 10.1002/cpt.1393

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Approach to the management of paediatric HIV spontaneous controllers.

Authors:  Peter Zuidewind; Mark Cotton; Shaun Barnabas; Anita Janse Van Rensburg; Gert van Zyl; Carli Gordijn
Journal:  S Afr J Infect Dis       Date:  2022-06-30

2.  Characteristics of 2-drug regimen users living with HIV-1 in a real-world setting: A large-scale medical claim database analysis in Japan.

Authors:  Daniel J Ruzicka; Mayuko Kamakura; Naho Kuroishi; Nobuyuki Oshima; Miyuki Yamatani; Jingbo Yi; Bruce Crawford; Kunihisa Tsukada; Shinichi Oka
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

Review 3.  A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

Authors:  Allison R Webel; Julie Schexnayder; Patricia A Cioe; Julie A Zuñiga
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

4.  Premature and early menopause among US women with or at risk for HIV.

Authors:  Brooke W Bullington; Andrew Edmonds; Catalina Ramirez; Lisa Rahangdale; Genevieve Neal-Perry; Deborah Konkle-Parker; Deborah Jones Weiss; Caitlin Moran; Elizabeth Topper Golub; Helen Cejtin; Dominika Seidman; Seble Kassaye; Tracey E Wilson; Anjali Sharma; Adaora A Adimora; Andrea K Knittel
Journal:  Menopause       Date:  2022-06-01       Impact factor: 3.310

Review 5.  The management of treatment-experienced HIV patients (including virologic failure and switches).

Authors:  James Cutrell; Tomasz Jodlowski; Roger Bedimo
Journal:  Ther Adv Infect Dis       Date:  2020-01-20

Review 6.  New Frontiers in Measuring and Characterizing the HIV Reservoir.

Authors:  Shane D Falcinelli; Cristina Ceriani; David M Margolis; Nancie M Archin
Journal:  Front Microbiol       Date:  2019-12-18       Impact factor: 5.640

Review 7.  Pharmacogenomics of Antiretroviral Drug Metabolism and Transport.

Authors:  Zaikuan J Yu; Eric P Mosher; Namandjé N Bumpus
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-09-22       Impact factor: 13.820

Review 8.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.